Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84.95 USD | +2.60% |
|
+4.57% | +6.73% |
07-09 | RBC Lifts Price Target on Axsome Therapeutics to $131 From $130, Keeps Outperform Rating | MT |
06-05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.73% | 4.03B | |
+7.75% | 100B | |
+8.42% | 42.34B | |
-13.04% | 32.76B | |
+80.80% | 29.46B | |
-10.92% | 16.31B | |
+1.93% | 14.39B | |
-6.77% | 12.23B | |
+177.16% | 10.47B | |
+4.12% | 8.97B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- RBC Lifts Price Target on Axsome Therapeutics to $131 From $130, Keeps Outperform Rating